AEK-3072039-3/11/1

AbbVie Deutschland GmbH & Co. KG — FEI 3002807401

Refusal Details

Date
March 31, 2023
Country
Germany
Product Category
Drugs and Biologics
Product Code
61YCY02 ADALIMUMAB
Charges
75